Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series.

Falcone F, Normanno N, Losito NS, Scognamiglio G, Esposito Abate R, Chicchinelli N, Casella G, Laurelli G, Scaffa C, Greggi S.

Eur J Obstet Gynecol Reprod Biol. 2019 Jul 13;240:220-225. doi: 10.1016/j.ejogrb.2019.07.013. [Epub ahead of print]

PMID:
31326637
2.

LncRNA HOTAIR in Tumor Microenvironment: What Role?

Botti G, Scognamiglio G, Aquino G, Liguori G, Cantile M.

Int J Mol Sci. 2019 May 8;20(9). pii: E2279. doi: 10.3390/ijms20092279. Review.

3.

Posterior HOX genes and HOTAIR expression in the proximal and distal colon cancer pathogenesis.

Tatangelo F, Di Mauro A, Scognamiglio G, Aquino G, Lettiero A, Delrio P, Avallone A, Cantile M, Botti G.

J Transl Med. 2018 Dec 12;16(1):350. doi: 10.1186/s12967-018-1725-y.

4.

Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature.

Sabbatino F, Marra A, Liguori L, Scognamiglio G, Fusciello C, Botti G, Ferrone S, Pepe S.

J Immunother Cancer. 2018 Nov 20;6(1):126. doi: 10.1186/s40425-018-0439-2.

5.

MicroRNA-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression.

Panza E, Ercolano G, De Cicco P, Armogida C, Scognamiglio G, Botti G, Cirino G, Ianaro A.

Biochem Pharmacol. 2018 Oct;156:52-59. doi: 10.1016/j.bcp.2018.08.008. Epub 2018 Aug 9.

PMID:
30098313
6.

Characterization of respiratory infection viruses in hospitalized children from Naples province in Southern Italy.

Botti C, Micillo A, Ricci G, Russo A, Denisco A, Cantile M, Scognamiglio G, De Rosa A, Botti G.

Exp Ther Med. 2018 Jun;15(6):4805-4809. doi: 10.3892/etm.2018.6061. Epub 2018 Apr 13.

7.

RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells.

Gallo M, Frezzetti D, Roma C, Chicchinelli N, Barbieri A, Arra C, Scognamiglio G, Botti G, De Luca A, Normanno N.

Oncotarget. 2018 Apr 3;9(25):17543-17553. doi: 10.18632/oncotarget.24784. eCollection 2018 Apr 3.

8.

Immune Checkpoint Inhibitors in Melanoma and HIV Infection.

Marra A, Scognamiglio G, Peluso I, Botti G, Fusciello C, Filippelli A, Ascierto PA, Pepe S, Sabbatino F.

Open AIDS J. 2017 Nov 14;11:91-100. doi: 10.2174/1874613601711010091. eCollection 2017. Review.

9.

Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.

Marra A, Ferrone CR, Fusciello C, Scognamiglio G, Ferrone S, Pepe S, Perri F, Sabbatino F.

Anticancer Agents Med Chem. 2018;18(2):166-181. doi: 10.2174/1871520618666171219115335. Review.

PMID:
29256359
10.

Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma.

Botti G, Scognamiglio G, Marra L, Pizzolorusso A, Di Bonito M, De Cecio R, Cantile M, De Chiara A.

J Cancer. 2017 Sep 15;8(16):3166-3172. doi: 10.7150/jca.19060. eCollection 2017.

11.

Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.

Ventriglia J, Paciolla I, Pisano C, Cecere SC, Di Napoli M, Tambaro R, Califano D, Losito S, Scognamiglio G, Setola SV, Arenare L, Pignata S, Della Pepa C.

Cancer Treat Rev. 2017 Sep;59:109-116. doi: 10.1016/j.ctrv.2017.07.008. Epub 2017 Jul 31. Review.

PMID:
28800469
12.

Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells.

Pisanu ME, Noto A, De Vitis C, Morrone S, Scognamiglio G, Botti G, Venuta F, Diso D, Jakopin Z, Padula F, Ricci A, Mariotta S, Giovagnoli MR, Giarnieri E, Amelio I, Agostini M, Melino G, Ciliberto G, Mancini R.

Cancer Lett. 2017 Oct 10;406:93-104. doi: 10.1016/j.canlet.2017.07.027. Epub 2017 Aug 7.

PMID:
28797843
13.

Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP.

Valentino E, Bellazzo A, Di Minin G, Sicari D, Apollonio M, Scognamiglio G, Di Bonito M, Botti G, Del Sal G, Collavin L.

Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):7623-7628. doi: 10.1073/pnas.1700996114. Epub 2017 Jun 30.

14.

New cell block containing agarose for cytopathological diagnosis of tumor samples.

Miceli R, Scognamiglio G, Camerlingo R, Rea G, Lettiero A, Cantile M, Greggi S, Losito NS, Pirozzi G, Botti G.

Diagn Cytopathol. 2017 Nov;45(11):1057-1060. doi: 10.1002/dc.23778. Epub 2017 Jun 30. No abstract available.

PMID:
28664554
15.

LncRNA HOTAIR Polymorphisms Association with Cancer Susceptibility in Different Tumor Types.

Botti G, Collina F, Scognamiglio G, Aquino G, Cerrone M, Liguori G, Gigantino V, Malzone MG, Cantile M.

Curr Drug Targets. 2018;19(10):1220-1226. doi: 10.2174/1389450118666170622091940.

PMID:
28641521
16.

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.

Carriero MV, Bifulco K, Ingangi V, Costantini S, Botti G, Ragone C, Minopoli M, Motti ML, Rea D, Scognamiglio G, Botti G, Arra C, Ciliberto G, Pessi A.

Sci Rep. 2017 May 2;7(1):1312. doi: 10.1038/s41598-017-01425-9.

17.

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

Botti G, Fratangelo F, Cerrone M, Liguori G, Cantile M, Anniciello AM, Scala S, D'Alterio C, Trimarco C, Ianaro A, Cirino G, Caracò C, Colombino M, Palmieri G, Pepe S, Ascierto PA, Sabbatino F, Scognamiglio G.

J Transl Med. 2017 Feb 23;15(1):46. doi: 10.1186/s12967-017-1150-7.

18.

Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients.

Botti G, Collina F, Scognamiglio G, Rao F, Peluso V, De Cecio R, Piezzo M, Landi G, De Laurentiis M, Cantile M, Di Bonito M.

Int J Mol Sci. 2017 Feb 21;18(2). pii: E459. doi: 10.3390/ijms18020459.

19.

CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients.

D'Alterio C, Nasti G, Polimeno M, Ottaiano A, Conson M, Circelli L, Botti G, Scognamiglio G, Santagata S, De Divitiis C, Nappi A, Napolitano M, Tatangelo F, Pacelli R, Izzo F, Vuttariello E, Botti G, Scala S.

Oncoimmunology. 2016 Nov 29;5(12):e1254313. doi: 10.1080/2162402X.2016.1254313. eCollection 2016.

20.

HOTAIR role in melanoma progression and its identification in the blood of patients with advanced disease.

Cantile M, Scognamiglio G, Marra L, Aquino G, Botti C, Falcone MR, Malzone MG, Liguori G, Di Bonito M, Franco R, Ascierto PA, Botti G.

J Cell Physiol. 2017 Dec;232(12):3422-3432. doi: 10.1002/jcp.25789. Epub 2017 Jun 5.

PMID:
28067428

Supplemental Content

Loading ...
Support Center